Physician

Gertrude K Shahady, MD

According to 2025 Medicare claims, Gertrude Shahady, MD (NPI: 1487639878) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Campbell, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24501-1131. Shahady is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Shahady's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 540 traditional Medicare patients, billed 11,624 HCPCS/CPT codes, and received $306,467 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,998 prescription claims across 777 beneficiaries totaling $1,343,313 in drug costs, led by Ozempic (Semaglutide). DME data shows 727 claims. Open Payments data shows 135 records totaling $2,278. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $71,381 and ending at $59,150.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	796	19,822	$262,971
2016	632	22,319	$278,181
2017	701	17,797	$265,282
2018	646	10,011	$288,317
2019	669	10,502	$257,469
2020	596	9,690	$242,628
2021	617	9,123	$263,732
2022	551	9,435	$269,939
2023	481	9,807	$272,696
2024	540	11,624	$306,467

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	804	16,189	$1,160,947
2016	770	16,122	$1,168,021
2017	688	14,970	$1,021,157
2018	712	13,358	$951,648
2019	668	12,463	$952,133
2020	646	11,805	$929,487
2021	679	12,312	$1,033,815
2022	714	12,430	$1,077,365
2023	726	12,940	$1,272,587
2024	777	13,998	$1,343,313

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	553	1,919	$66,039
2016	537	1,759	$46,546
2017	489	1,543	$37,725
2018	442	1,430	$29,231
2019	372	1,274	$26,543
2020	323	976	$31,977
2021	165	640	$23,335
2022	154	586	$27,572
2023	139	529	$34,192
2024	139	727	$51,948

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	461	903	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	384	656	$11
36415	Insertion of needle into vein for collection of blood sample	396	726	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	357	581	$8
80076	Liver function blood test panel	346	534	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	100	4,486	$139,492
Mounjaro	Tirzepatide	119	3,594	$129,788
Jardiance	Empagliflozin	104	5,799	$111,471
Eliquis	Apixaban	88	5,061	$96,205
Trulicity	Dulaglutide	37	1,542	$49,177

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	19	93	$32,423
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	76	$5,259
A7032	Cushion for use on nasal mask interface, replacement only, each	N	14	41	$4,098
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	16	48	$2,425
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	58	$1,713

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	135	$2,278	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gertrude K. Shahady, MD?

Tedicare shows public-source Medicare data for Gertrude K. Shahady, MD (NPI 1487639878), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gertrude K. Shahady, MD have ACO affiliation data?

Gertrude K. Shahady, MD is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Gertrude K. Shahady, MD?

Gertrude K. Shahady, MD is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Gertrude K. Shahady, MD have Open Payments data?

Gertrude K. Shahady, MD has 135 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.